Bioactive anti-inflammatory coating for chronic neural electrodes

Autor: Yosi Shacham-Diamand, Ari Magal, Roni Hogri, Matti Mintz, Aryeh H. Taub
Rok vydání: 2012
Předmět:
Deep brain stimulation
Materials science
medicine.drug_class
medicine.medical_treatment
0206 medical engineering
Anti-Inflammatory Agents
Biomedical Engineering
02 engineering and technology
Pharmacology
Glial scar
Rats
Sprague-Dawley

Biomaterials
03 medical and health sciences
0302 clinical medicine
Immune system
Glial Fibrillary Acidic Protein
medicine
Animals
Receptor
Electrodes
030304 developmental biology
Neurons
0303 health sciences
Glial fibrillary acidic protein
biology
Metals and Alloys
Interleukin
021001 nanoscience & nanotechnology
Receptor antagonist
020601 biomedical engineering
Immunohistochemistry
Rats
Interleukin 1 Receptor Antagonist Protein
Interleukin 1 receptor antagonist
Immunology
Ceramics and Composites
biology.protein
0210 nano-technology
030217 neurology & neurosurgery
Zdroj: Journal of Biomedical Materials Research Part A. :1854-1858
ISSN: 1549-3296
DOI: 10.1002/jbm.a.34152
Popis: Chronic electrodes are widely used for brain degenerative and psychiatric diseases such as Parkinson's disease,major depression, and obsessive-compulsive disorder, and for neuronal prosthesis. Brain immune reaction to electrodes in the form of glial scar encapsulates the electrode and reduces the efficacy of deep brain stimulation and neuronal prosthesis.State-of-the-art strategies for improving brain–electrode interface use passive protein coating to "camouflage" the electrode from the immune system. In this study, we actively reduced the brain immune reaction to the chronic electrodes using immune suppressing protein, that is, interleukin (IL)-1 receptor antagonist. IL-1 receptor antagonist-coated electrodes and non coated electrodes were chronically implanted in rats. An additional group of rats was chronically implanted with IL-1 receptor antagonist- and laminin-coated electrodes (as passive protein). Examination of glial scaring 1 and 4 weeks after implantation indicated a significant reduction in the amount of glial scar in the vicinity of the IL-1 receptor antagonist-coated electrode in comparison to both non coated electrode and laminin-coated electrodes. The results strongly suggest that active immune suppressing protein reduces the level of immune reaction to chronic electrodes already after 1 week after implantation and generates less immune reaction than passive protein coating [corrected].
Databáze: OpenAIRE